Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Cash from Investing Activities: 2010-2025

Historic Cash from Investing Activities for Prestige Consumer Healthcare (PBH) over the last 16 years, with Mar 2025 value amounting to -$17.5 million.

  • Prestige Consumer Healthcare's Cash from Investing Activities fell 44.50% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.2 million, marking a year-over-year increase of 23.23%. This contributed to the annual value of -$17.5 million for FY2025, which is 13.22% up from last year.
  • Prestige Consumer Healthcare's Cash from Investing Activities amounted to -$17.5 million in FY2025, which was up 13.22% from -$20.1 million recorded in FY2024.
  • Prestige Consumer Healthcare's 5-year Cash from Investing Activities high stood at -$11.6 million for FY2023, and its period low was -$256.5 million during FY2022.
  • Its 3-year average for Cash from Investing Activities is -$16.4 million, with a median of -$17.5 million in 2025.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Cash from Investing Activities crashed by 1,053.22% in 2022 and then spiked by 95.48% in 2023.
  • Prestige Consumer Healthcare's Cash from Investing Activities (Yearly) stood at -$22.2 million in 2021, then slumped by 1,053.22% to -$256.5 million in 2022, then skyrocketed by 95.48% to -$11.6 million in 2023, then tumbled by 73.61% to -$20.1 million in 2024, then grew by 13.22% to -$17.5 million in 2025.